Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Clinical trial NCT06671548 · RECRUITING
Trial details
- NCT number
- NCT06671548
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-15
- Primary completion
- 2026-11-12
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.